Article
Deep learning predicts patients’ outcome and mutations from H&E slides in Gastrointestinal stromal tumor (GIST)
2022-09-27
Abstract excerpt
<title>Abstract</title> <p><bold>Background. </bold>Most gastrointestinal stromal tumors (GIST) have activating mutations of <italic>KIT</italic>or <italic>PDGFRA</italic> genes and imatinib has proven effective in palliative and adjuvant situations. Risk assessment according to the AFIP/Miettinen classification and mutational profiling are major tools for management of patients with GIST. However, the AFIP/Miett...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4867393c-05be-546d-b2d8-febbf8c98f33
- DOI
- 10.21203/rs.3.rs-2080092/v1
